Our mission
To improve patients’ lives
Acting on this mission has propelled us to become a global biopharmaceutical leader with a focus on innovation and specialty care.
Our passion drives our commitment to patients living with difficult-to-treat diseases, and we put them first. Because patients are our priority, we help them through our expertise in oncology, neuroscience, and rare disease.
We bring medicines to patients with the strength of nearly 6,000 employees across the globe, including innovators in our key therapeutic areas.
Download our annual reportAbout
Oncology
Our oncology work focuses on solid tumors and some of the hardest-to-treat cancers. We power a growing portfolio of therapies aimed at improving the lives of patients with gastrointestinal and pancreatic neuroendocrine tumors, carcinoid syndrome, pancreatic cancer, follicular lymphoma and epithelioid sarcoma.
Neuroscience
People suffering from neurological disorders are in need of treatments, and we’ve become a global leader in creating them through the research, development, manufacturing and commercialization of neurotoxins to help treat certain types of spasticity in adults and children two years and older, and cervical dystonia in adults.
Rare disease
We continue to evolve and grow our research efforts in the area of rare and ultra-rare disease. Given the limited understanding of these diseases, we are committed to addressing patient needs, from supporting diagnosis to treatment with specific investment in pituitary pathologies, growth disorders, liver disease and ultra-rare bone diseases, including fibrodysplasia ossificans progressiva, commonly known as FOP.
Clinical Trials
Clinical trials can lead to medical outcomes that help improve lives, and we thank all of our patients who make this critical research possible through their participation in trials. If you would like to learn more about enrolling in a study, visit clinicaltrials.gov.
Meet our leadership team
Stewart Campbell
Executive Vice President, President, North America
Shahrzad Amirani
Vice President, Head of New Products & Innovation
Kimberly Baldwin
Vice President, Value & Access
Elliot Beimel
Vice President, Finance, North America
Jennifer Benenson
Senior Vice President and North America General Counsel, Legal Affairs
David Daya
Senior Vice President, Franchise Head, Oncology Business Unit
Monica de Abadal
Senior Vice President, Head of Medical Affairs, North America
Ed Dybka
General Manager, Ipsen Canada
Clemence Elie
Senior Vice President, Head of North America Human Resources
Liz Kalina
Vice President, Communications and Patient Advocacy
Ali Lyons
VP, Business Ethics North America
Eduardo Obraczka
Vice President and Franchise Head, Rare Diseases North America
Mike Patterson
Vice President, Business Operations & Strategy and Chief of Staff
Drew Sansone
Vice President, Regulatory Affairs, Quality & Safety, North America
Chris Watters
Vice President, Franchise Head, Neuroscience Business Unit
Leadership